Previous Close | 37.86 |
Open | 38.11 |
Bid | 38.70 x 400 |
Ask | 38.90 x 200 |
Day's Range | 37.67 - 39.25 |
52 Week Range | 11.39 - 40.13 |
Volume | |
Avg. Volume | 1,025,793 |
Market Cap | 3.176B |
Beta (5Y Monthly) | 0.42 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.00 |
Earnings Date | Nov 04, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 46.57 |
LONDON and RALEIGH, N.C., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that senior management will present a company overview at the following conferences in December 2024: Piper Sandler 36th Annual Healthcare ConferenceDate: Tuesday, December 3, 2024Time: 12:00 p.m. ET / 5:00 p.m. GMTLocation: New York, NY 7th Annual Evercore HealthCONx ConferenceDate: Wednesday, December 4, 2024Time: 3:00 p.m. ET / 8:00 p.m. GMTLocation: Miami,
For many, the main point of investing in the stock market is to achieve spectacular returns. While not every stock...